Jennifer Kim's Stock Ratings

Cantor Fitzgerald Analyst

Jennifer Kim is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/20/2025

Overall Average Return

10.7%

Smart Score

61%

Overall Average Return Percentile

63rd

Number of Ratings

49
Buy NowGet Alert
05/15/2025BLTEBuy Now
Belite Bio
$61.10
Jennifer Kim61%
ReiteratesOverweight → OverweightGet Alert
05/15/2025PGENBuy Now
Precigen
$1.45
Jennifer Kim61%
ReiteratesOverweight → OverweightGet Alert
03/18/2025BLTEBuy Now
Belite Bio
$61.10
Jennifer Kim61%
ReiteratesOverweight → OverweightGet Alert
02/20/2025INSMBuy Now
Insmed
$102.40
Jennifer Kim61%
ReiteratesOverweight → OverweightGet Alert
02/19/2025INSMBuy Now
Insmed
$102.40
Jennifer Kim61%
ReiteratesOverweight → OverweightGet Alert
06/20/2024INSMBuy Now
Insmed
$102.40
Jennifer Kim61%
Reiterates → OverweightGet Alert
06/20/2024FBIOBuy Now
Fortress Biotech
$1.82
Jennifer Kim61%
Reiterates → OverweightGet Alert
06/20/2024EYPTBuy Now
EyePoint Pharmaceuticals
$8.64
Jennifer Kim61%
Reiterates → OverweightGet Alert
06/20/2024BLTEBuy Now
Belite Bio
$61.10
Jennifer Kim61%
Reiterates → OverweightGet Alert
06/20/2024ALLKBuy Now
Allakos
Jennifer Kim61%
Reiterates → NeutralGet Alert
05/15/2024BLTEBuy Now
Belite Bio
$61.10
Jennifer Kim61%
Reiterates → OverweightGet Alert
05/15/2024PGENBuy Now
Precigen
$1.45
Jennifer Kim61%
Reiterates → OverweightGet Alert
10/10/2023PSTXBuy Now
Poseida Therapeutics
Jennifer Kim61%
→ $14ReiteratesOverweight → OverweightGet Alert
09/21/2023INSMBuy Now
Insmed
$102.40-47.27%
Jennifer Kim61%
$46 → $54MaintainsOverweightGet Alert
09/19/2023INSMBuy Now
Insmed
$102.40-55.08%
Jennifer Kim61%
→ $46ReiteratesOverweight → OverweightGet Alert
09/14/2023EYPTBuy Now
EyePoint Pharmaceuticals
$8.64258.8%
Jennifer Kim61%
→ $31ReiteratesOverweight → OverweightGet Alert
08/31/2023OCGNBuy Now
Ocugen
$1.0590.48%
Jennifer Kim61%
$2.5 → $2MaintainsOverweightGet Alert
08/31/2023EYPTBuy Now
EyePoint Pharmaceuticals
$8.64258.8%
Jennifer Kim61%
→ $31ReiteratesOverweight → OverweightGet Alert
08/15/2023FBIOBuy Now
Fortress Biotech
$1.82174.86%
Jennifer Kim61%
→ $5ReiteratesOverweight → OverweightGet Alert
08/15/2023CKPTBuy Now
Checkpoint Therapeutics
Jennifer Kim61%
$19 → $14MaintainsOverweightGet Alert
07/28/2023BLTEBuy Now
Belite Bio
$61.10-29.62%
Jennifer Kim61%
→ $43Initiates → OverweightGet Alert
07/27/2023LPCNBuy Now
Lipocine
$3.30900%
Jennifer Kim61%
→ $33ReiteratesOverweight → OverweightGet Alert
06/28/2023EYPTBuy Now
EyePoint Pharmaceuticals
$8.64258.8%
Jennifer Kim61%
→ $31ReiteratesOverweight → OverweightGet Alert
05/17/2023PRQRBuy Now
ProQR Therapeutics
$1.94131.96%
Jennifer Kim61%
$5 → $4.5MaintainsOverweightGet Alert
05/16/2023CKPTBuy Now
Checkpoint Therapeutics
Jennifer Kim61%
$54 → $19MaintainsOverweightGet Alert
05/16/2023FBIOBuy Now
Fortress Biotech
$1.82174.86%
Jennifer Kim61%
$6 → $5MaintainsOverweightGet Alert
03/31/2023NOVNBuy Now
Novan
Jennifer Kim61%
→ $8Reiterates → OverweightGet Alert
03/07/2023ALLKBuy Now
Allakos
Jennifer Kim61%
→ $7Reiterates → OverweightGet Alert
02/27/2023ALLKBuy Now
Allakos
Jennifer Kim61%
→ $7Reiterates → OverweightGet Alert
02/24/2023INSMBuy Now
Insmed
$102.40-55.08%
Jennifer Kim61%
$49 → $46MaintainsOverweightGet Alert
02/01/2023PSTXBuy Now
Poseida Therapeutics
Jennifer Kim61%
→ $24Reiterates → OverweightGet Alert
01/30/2023PGENBuy Now
Precigen
$1.45589.66%
Jennifer Kim61%
$7 → $10MaintainsOverweightGet Alert
01/04/2023CKPTBuy Now
Checkpoint Therapeutics
Jennifer Kim61%
→ $15MaintainsOverweightGet Alert
12/22/2022PRQRBuy Now
ProQR Therapeutics
$1.94157.73%
Jennifer Kim61%
$0.8 → $5UpgradeNeutral → OverweightGet Alert
11/18/2022PGENBuy Now
Precigen
$1.45382.76%
Jennifer Kim61%
→ $7Initiates → OverweightGet Alert
10/25/2022INSMBuy Now
Insmed
$102.40-52.15%
Jennifer Kim61%
$53 → $49MaintainsOverweightGet Alert
09/12/2022ALLKBuy Now
Allakos
Jennifer Kim61%
$10 → $7MaintainsOverweightGet Alert
06/02/2022OCGNBuy Now
Ocugen
$1.05328.57%
Jennifer Kim61%
→ $4.5Initiates → OverweightGet Alert
05/17/2022AYTUBuy Now
Aytu BioPharma
$2.02147.59%
Jennifer Kim61%
$11 → $5MaintainsOverweightGet Alert
03/17/2022GRAYBuy Now
Graybug Vision
Jennifer Kim61%
$6 → $4MaintainsOverweightGet Alert
10/08/2021INSMBuy Now
Insmed
$102.40-41.41%
Jennifer Kim61%
→ $60Initiates → OverweightGet Alert
07/09/2021NOVNBuy Now
Novan
Jennifer Kim61%
→ $30Initiates → OverweightGet Alert
06/24/2021LPCNBuy Now
Lipocine
$3.30-9.09%
Jennifer Kim61%
→ $3Initiates → OverweightGet Alert
03/30/2021AYTUBuy Now
Aytu BioPharma
$2.02444.69%
Jennifer Kim61%
→ $11Initiates → OverweightGet Alert
01/28/2021EYPTBuy Now
EyePoint Pharmaceuticals
$8.64154.63%
Jennifer Kim61%
→ $22Initiates → OverweightGet Alert
01/27/2021EYPTBuy Now
EyePoint Pharmaceuticals
$8.64154.63%
Jennifer Kim61%
→ $22Initiates → OverweightGet Alert
01/20/2021CKPTBuy Now
Checkpoint Therapeutics
Jennifer Kim61%
→ $16Initiates → OverweightGet Alert
12/22/2020GRAYBuy Now
Graybug Vision
Jennifer Kim61%
→ $42Initiates → OverweightGet Alert
02/13/2020FBIOBuy Now
Fortress Biotech
$1.82229.83%
Jennifer Kim61%
→ $6Initiates → OverweightGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free